Besides increasing levels of serum bilirubin, liver disease progression can be preceded or accompanied by the increased expression of various growth factors, such as alanine aminotransferase (ALT) or alkaline phosphatase (AP), respectively reflecting hepatocellular injury or de novo synthesis in hepatic tissue [8,9]. This evidence concerns the gene GPT and liver disorder.